Key result
Percutaneous cardiac therapies provide a minimally invasive alternative to coronary-artery bypass grafting for patients with heart disease, often with fewer peri-procedural complications.
Percutaneous cardiac therapies are highlighted as a minimally invasive alternative to CABG with potentially fewer peri-procedural complications.
Answers are grounded in this paper and cite their sources.
May support percutaneous options to limit complications in select patients; leaves open need for randomized trials on long-term outcomes.
A significant proportion of patients who sufferfrom heart disease have both these predisposing factors andother comorbidities, making their management more difficult.While medical treatment of heart conditions has helped toextend the durability of the native heart, many patients willeventually reach a point where invasive surgical manoeuvreshave to be considered.Fortunately, there is an emerging field in cardiovascular med -icine that can provide a new alternative for these patients: per-cutaneous cardiac therapies. These procedures are minimallyinvasive and are often associated with fewer peri-proceduralcomplications than a coronary-artery bypass graft (CABG), lead -ing to fewer subsequent morbidities.
No takes yet. Share an insight, caveat, or question.
T Soeyonggo (2010) conducted a review in Heart disease. Percutaneous cardiac therapies vs. Coronary-artery bypass graft (CABG) was evaluated. Percutaneous cardiac therapies provide a minimally invasive alternative to coronary-artery bypass grafting for patients with heart disease, often with fewer peri-procedural complications.
Synapse has enriched 10 related papers. Consider them for comparative context: